Skip to main content

Home/ Cancer/ Group items tagged new hnca therapy Novel

Rss Feed Group items tagged

Matti Narkia

Novel therapy for cancer? from - 0 views

    A ground-breaking Canada-wide clinical trial led by Dr. Katherine Borden, at the Institute for Research in Immunology and Cancer (IRIC) of the Universit de Montral, has shown that a common anti-viral drug, ribavirin, can be beneficial in the treatment of cancer patients. Published in the journal Blood (First Edition), the study demonstrates that ribavirin suppresses the activities of the eIF4E gene in patients. This gene is dysregulated in 30 percent of cancers including breast, prostate, head and neck, colon and stomach cancer.
1 - 1 of 1
Showing 20 items per page